147 related articles for article (PubMed ID: 7903060)
1. Synthesis of a [11C]methoxy derivative of alpha-dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter.
DaSilva JN; Kilbourn MR; Mangner TJ
Appl Radiat Isot; 1993 Dec; 44(12):1487-9. PubMed ID: 7903060
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of the brain vesicular monoamine transporter.
Vander Borght TM; Kilbourn MR; Koeppe RA; DaSilva JN; Carey JE; Kuhl DE; Frey KA
J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116
[TBL] [Abstract][Full Text] [Related]
3. Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
Canney DJ; Kung MP; Kung HF
Nucl Med Biol; 1995 May; 22(4):527-35. PubMed ID: 7550031
[TBL] [Abstract][Full Text] [Related]
4. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
[TBL] [Abstract][Full Text] [Related]
5. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
Kilbourn M; Lee L; Vander Borght T; Jewett D; Frey K
Eur J Pharmacol; 1995 May; 278(3):249-52. PubMed ID: 7589162
[TBL] [Abstract][Full Text] [Related]
6. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE
J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605
[TBL] [Abstract][Full Text] [Related]
7. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
Koeppe RA; Frey KA; Vander Borght TM; Karlamangla A; Jewett DM; Lee LC; Kilbourn MR; Kuhl DE
J Cereb Blood Flow Metab; 1996 Nov; 16(6):1288-99. PubMed ID: 8898703
[TBL] [Abstract][Full Text] [Related]
8. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
Kilbourn MR; Kuszpit K; Sherman P
Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
Lee LC; Vander Borght T; Sherman PS; Frey KA; Kilbourn MR
J Med Chem; 1996 Jan; 39(1):191-6. PubMed ID: 8568807
[TBL] [Abstract][Full Text] [Related]
10. Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.
Kilbourn M; Frey K
Eur J Pharmacol; 1996 Jun; 307(2):227-32. PubMed ID: 8832225
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 10-(11) C-dihydrotetrabenazine as a vesicular monoamine transporter 2 radioligand.
Li X; Chen Z; Tang J; Liu C; Zou P; Huang H; Tan C; Yu H
Arch Pharm (Weinheim); 2014 May; 347(5):313-9. PubMed ID: 24497196
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography.
Kilbourn MR; DaSilva JN; Frey KA; Koeppe RA; Kuhl DE
J Neurochem; 1993 Jun; 60(6):2315-8. PubMed ID: 8492135
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.
Chan GL; Holden JE; Stoessl AJ; Samii A; Doudet DJ; Dobko T; Morrison KS; Adam M; Schulzer M; Calne DB; Ruth TJ
J Nucl Med; 1999 Feb; 40(2):283-9. PubMed ID: 10025836
[TBL] [Abstract][Full Text] [Related]
14. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters.
Kilbourn MR; Frey KA; Vander Borght T; Sherman PS
Nucl Med Biol; 1996 May; 23(4):467-71. PubMed ID: 8832701
[TBL] [Abstract][Full Text] [Related]
15. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
Huang ZR; Tsai CL; Huang YY; Shiue CY; Tzen KY; Yen RF; Hsin LW
PLoS One; 2016; 11(9):e0161295. PubMed ID: 27612194
[TBL] [Abstract][Full Text] [Related]
16. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
Taylor SF; Koeppe RA; Tandon R; Zubieta JK; Frey KA
Neuropsychopharmacology; 2000 Dec; 23(6):667-75. PubMed ID: 11063922
[TBL] [Abstract][Full Text] [Related]
17. [Quick and simple synthesis of (11)C-(+)-alpha-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters].
Quincoces G; Collantes M; Catalán R; Ecay M; Prieto E; Martino E; Blesa FJ; Alvarez-Erviti L; Areses P; Arbizu J; Obeso JA; Martí-Climent JM; Richter JA; Peñuelas I
Rev Esp Med Nucl; 2008; 27(1):13-21. PubMed ID: 18208777
[TBL] [Abstract][Full Text] [Related]
18. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
Kilbourn MR; Sherman PS; Kuszpit K
Synapse; 2002 Mar; 43(3):188-94. PubMed ID: 11793424
[TBL] [Abstract][Full Text] [Related]
19. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography.
Gilman S; Koeppe RA; Adams KM; Junck L; Kluin KJ; Johnson-Greene D; Martorello S; Heumann M; Bandekar R
Ann Neurol; 1998 Sep; 44(3):326-33. PubMed ID: 9749598
[TBL] [Abstract][Full Text] [Related]
20. In vivo binding of (+)-alpha-[3H]dihydrotetrabenazine to the vesicular monoamine transporter of rat brain: bolus vs. equilibrium studies.
Kilbourn M; Sherman P
Eur J Pharmacol; 1997 Jul; 331(2-3):161-8. PubMed ID: 9274975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
